Home/Filings/4/0000899243-23-001599
4//SEC Filing

HENNER DENNIS 4

Accession 0000899243-23-001599

CIK 0001623715other

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 4:16 PM ET

Size

8.5 KB

Accession

0000899243-23-001599

Insider Transaction Report

Form 4
Period: 2023-01-11
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-01-1111,9040 total
    Exercise: $15.65Exp: 2032-05-31Common Stock (11,904 underlying)
  • Disposition from Tender

    Common Stock

    2023-01-11$36.00/sh26,095$939,4200 total
Footnotes (2)
  • [F1]On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement"), by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. Pursuant to the Merger Agreement, each option to purchase common stock of the Issuer, whether vested or unvested, outstanding immeditately prior to the effective time of the Merger, was exchanged for a cash payment equal to (x) the aggregate number of shares of the Issuer's common stock subject to such option, multiplied by (y) the excess, if any, of $36.00 over the per share exercise price under such option.
  • [F2]The Reporting Person disclaims beneficial ownership of these securities and the inclusion of the securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or any other purpose. The Reporting Person is an employee of Blackstone Inc. or one of its affiliates ("Blackstone"). Pursuant to arrangements between the Reporting Person and Blackstone, the Reporting Person is required to transfer to Blackstone any and all compensation received in connection with his directorship for any company Blackstone invests in or advises.

Issuer

Imago BioSciences, Inc.

CIK 0001623715

Entity typeother

Related Parties

1
  • filerCIK 0001249153

Filing Metadata

Form type
4
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 4:16 PM ET
Size
8.5 KB